Mohammad Hirmand Buys 38,040 Shares of WHWK
Insider Mohammad Hirmand purchased 38,040 shares of WHWK on June 12, 2026.
Key Points
- On June 12, 2026, Mohammad Hirmand bought 38,040 shares of WHWK at a price of $0.00 per share.
- Shares of WHWK traded near $4.16, with several peer funds maintaining stable positions.
- Analysts from Citizens and Jones Trading initiated buy ratings with price targets of $8.00 and $7.00, respectively.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 12, 2026, Mohammad Hirmand made a significant move by purchasing 38,040 shares of WHWK. The shares were acquired at a price of $0.00, according to the transaction details. This insider buy adds to the company's overall insider activity, which included similar transactions by other insiders on the same date.
Other Institutional Activity in WHWK
While Mohammad Hirmand and other insiders were active in acquiring shares, several institutional investors maintained their holdings in WHWK. QVT Financial LP holds 4,615,709 shares valued at about $15.92 million. Orbimed Advisors LLC has a stake of 4,166,000 shares worth approximately $14.37 million. Suvretta Capital Management, LLC's position stands at 3,700,000 shares with a value of $12.77 million. Acuta Capital Partners, LLC holds 3,410,402 shares valued at $11.77 million, and Avoro Capital Advisors LLC owns 2,849,402 shares worth about $9.83 million. KVP Capital Advisors, LP maintains 2,165,997 shares, valued at $7.47 million.
Whitehawk Therapeutics, Inc. Stock Down 10.0%
Shares of WHWK are trading near $4.16. The company has seen stable interest from various institutional investors, as reflected in the unchanged holdings by several major funds.
$WHWK stock price
Daily closing prices, year to date. Not investment advice.
Insider Buying and Selling at Whitehawk Therapeutics, Inc.
In addition to Mohammad Hirmand, several insiders purchased shares of WHWK on June 12, 2026. These include Caley Castelein, Neil Desai, Emma Reeve, Richard Maroun, Zhao Baiteng, and Behzad Aghazadeh, each acquiring 38,040 shares at a price of $0.00 per share. None of these transactions were planned under Rule 10b5-1.
Analysts Set New Price Targets
On April 16, 2026, Citizens initiated coverage on WHWK with a buy rating and an $8.00 price target. Earlier, on December 22, 2025, Jones Trading also initiated coverage with a buy rating, setting a price target of $7.00. The consensus among analysts reflects a positive outlook for WHWK, supported by these recent ratings.
Bottom Line
Mohammad Hirmand's recent purchase of WHWK shares highlights ongoing insider interest in the company. This activity, alongside stable institutional holdings, suggests a continued belief in the company's prospects. Analysts have shown optimism with new buy ratings and price targets, but remember that insider purchases are not always indicative of future performance.
Get Whitehawk Therapeutics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $WHWK, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.